Literature DB >> 19995843

Primary progressive multiple sclerosis diagnostic criteria: a reappraisal.

X Montalban1, J Sastre-Garriga, M Filippi, Z Khaleeli, N Téllez, M M Vellinga, C Tur, B Brochet, F Barkhof, M Rovaris, D H Miller, C H Polman, A Rovira, A J Thompson.   

Abstract

The diagnostic criteria used in primary progressive (PP) and relapsing-remitting (RR) multiple sclerosis (MS) show substantial differences. This introduces complexity in the diagnosis of MS which could be resolved if these criteria could be unified in terms of the requirements for dissemination in space (DIS). The aim of this study was to assess whether a single algorithm may be used to demonstrate DIS in all forms of MS. Five sets of RRMS criteria for DIS were applied to a cohort of 145 patients with established PPMS (mean disease duration: 11 years - PPMS-1): C1: Barkhof-Tintoré (as in 2005 McDonald's criteria); C2: Swanton et al. (as in JNNP 2006); C3: presence of oligoclonal bands plus two lesions (as in McDonald's criteria); C4 and C5: a two-step approach was also followed (patients not fulfilling C1 or C2 were then assessed for C3). Two sets of PPMS criteria for DIS were applied: C6: Thompson et al. (as in 2001 McDonald's criteria); C7: 2005 McDonald criteria. A second sample of 55 patients with less than 5 years of disease duration (PPMS-2) was also analysed using an identical approach. For PPMS-1/PPMS-2, fulfilment was: C1:73.8%/66.7%; C2:72.1%/59.3%; C3:89%/79.2%; C4:96%/92.3%; C5:96%/85.7%; C6:85.8%/78.7%; C7:91%/80.4%. Levels of fulfilment suggest that the use of a single set of criteria for DIS in RRMS and PPMS might be feasible, and reinforce the added value of cerebrospinal fluid (CSF) findings to increase fulfilment in PPMS. Unification of the DIS criteria for both RRMS and PPMS could be considered in further revisions of the MS diagnostic criteria.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19995843     DOI: 10.1177/1352458509348422

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  10 in total

1.  Overcoming the clinical-MR imaging paradox of multiple sclerosis: MR imaging data assessed with a random forest approach.

Authors:  K Kacar; M A Rocca; M Copetti; S Sala; S Mesaros; T Stosic Opincal; D Caputo; M Absinta; J Drulovic; V S Kostic; G Comi; M Filippi
Journal:  AJNR Am J Neuroradiol       Date:  2011-11-11       Impact factor: 3.825

2.  [Diagnosis of multiple sclerosis 2010 revision of the McDonald criteria].

Authors:  L Klotz; R Gold; B Hemmer; T Korn; F Zipp; R Hohlfeld; B C Kieseier; H Wiendl
Journal:  Nervenarzt       Date:  2011-10       Impact factor: 1.214

Review 3.  Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis-clinical implementation in the diagnostic process.

Authors:  Àlex Rovira; Mike P Wattjes; Mar Tintoré; Carmen Tur; Tarek A Yousry; Maria P Sormani; Nicola De Stefano; Massimo Filippi; Cristina Auger; Maria A Rocca; Frederik Barkhof; Franz Fazekas; Ludwig Kappos; Chris Polman; David Miller; Xavier Montalban
Journal:  Nat Rev Neurol       Date:  2015-07-07       Impact factor: 42.937

4.  Altered neural mechanisms of cognitive control in patients with primary progressive multiple sclerosis: An effective connectivity study.

Authors:  Ekaterina Dobryakova; Maria Assunta Rocca; Paola Valsasina; John DeLuca; Massimo Filippi
Journal:  Hum Brain Mapp       Date:  2017-02-16       Impact factor: 5.038

5.  Determinants of Disability in Progressive Onset Multiple Sclerosis.

Authors:  Melih Tütüncü; Mesude Tütüncü; Sabahattin Saip; Aksel Siva
Journal:  Noro Psikiyatr Ars       Date:  2020-06-09       Impact factor: 1.339

6.  Proteomics comparison of cerebrospinal fluid of relapsing remitting and primary progressive multiple sclerosis.

Authors:  Marcel P Stoop; Vaibhav Singh; Lennard J Dekker; Mark K Titulaer; Christoph Stingl; Peter C Burgers; Peter A E Sillevis Smitt; Rogier Q Hintzen; Theo M Luider
Journal:  PLoS One       Date:  2010-08-27       Impact factor: 3.240

7.  Cervical cord FMRI abnormalities differ between the progressive forms of multiple sclerosis.

Authors:  Paola Valsasina; Maria A Rocca; Martina Absinta; Federica Agosta; Domenico Caputo; Giancarlo Comi; Massimo Filippi
Journal:  Hum Brain Mapp       Date:  2011-08-25       Impact factor: 5.038

8.  Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria.

Authors:  Chris H Polman; Stephen C Reingold; Brenda Banwell; Michel Clanet; Jeffrey A Cohen; Massimo Filippi; Kazuo Fujihara; Eva Havrdova; Michael Hutchinson; Ludwig Kappos; Fred D Lublin; Xavier Montalban; Paul O'Connor; Magnhild Sandberg-Wollheim; Alan J Thompson; Emmanuelle Waubant; Brian Weinshenker; Jerry S Wolinsky
Journal:  Ann Neurol       Date:  2011-02       Impact factor: 10.422

Review 9.  MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines.

Authors:  Massimo Filippi; Maria A Rocca; Olga Ciccarelli; Nicola De Stefano; Nikos Evangelou; Ludwig Kappos; Alex Rovira; Jaume Sastre-Garriga; Mar Tintorè; Jette L Frederiksen; Claudio Gasperini; Jacqueline Palace; Daniel S Reich; Brenda Banwell; Xavier Montalban; Frederik Barkhof
Journal:  Lancet Neurol       Date:  2016-01-26       Impact factor: 44.182

Review 10.  Spinal Cord Involvement in MS and Other Demyelinating Diseases.

Authors:  Mariano Marrodan; María I Gaitán; Jorge Correale
Journal:  Biomedicines       Date:  2020-05-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.